See also this year's filing and all EDGAR filings for this company.
PDF Report 0001253689_2017_Crescent_Biopharma_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001253689, Crescent Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 40,520,144 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,056,332 |
| 3 | remainder_Assets | 811,851 |
| 4 | LiabilitiesCurrent | 6,333,617 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 753,579 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,650,165 |
| 9 | ResearchAndDevelopmentExpense | 23,281,820 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 18,500 |
| 12 | remainder_NetIncome | 103,647 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 42,388,327 |
| 1 | Liabilities | 7,087,196 |
| 2 | Expenses | 31,931,985 |
| 3 | Revenues | 18,500 |
| 4 | StockholdersEquity | 35,301,131 |
| 5 | NetIncome | -31,809,838 |
| 6 | ComprehensiveNetIncome | -31,809,838 |
| 7 | BaseVar | 40,764,828 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.83 |
| 9 | EconomicCapitalRatio | 2.91 |